MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 412172 | Name: Xylamidine tosylate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Xylamidine tosylate is a Serotonin inhibitor with reproductive effects

Chemical Structure

Xylamidine tosylate
Xylamidine tosylate
CAS#6443-40-9

Theoretical Analysis

MedKoo Cat#: 412172

Name: Xylamidine tosylate

CAS#: 6443-40-9

Chemical Formula: C26H32N2O5S

Exact Mass: 484.2032

Molecular Weight: 484.61

Elemental Analysis: C, 64.44; H, 6.66; N, 5.78; O, 16.51; S, 6.62

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Xylamidine tosylate; BW545C64; BW-545C64; BW 545C64
IUPAC/Chemical Name
Acetamidine, N-(2-(m-methoxyphenoxy)propyl)-2-(m-tolyl)-, mono-p-toluenesulfonate
InChi Key
FRJLUWKYXWADTA-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H24N2O2.C7H8O3S/c1-14-6-4-7-16(10-14)11-19(20)21-13-15(2)23-18-9-5-8-17(12-18)22-3;1-6-2-4-7(5-3-6)11(8,9)10/h4-10,12,15H,11,13H2,1-3H3,(H2,20,21);2-5H,1H3,(H,8,9,10)
SMILES Code
N=C(NCC(OC1=CC=CC(OC)=C1)C)CC2=CC=CC(C)=C2.CC3=CC=C(S(=O)(O)=O)C=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 484.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ishigami T, Yoshioka K, Karicheti V, Marson L. A role for peripheral 5-HT2 receptors in serotonin-induced facilitation of the expulsion phase of ejaculation in male rats. J Sex Med. 2013 Nov;10(11):2688-702. doi: 10.1111/jsm.12306. Epub 2013 Sep 12. PMID: 24024794. 2: Lacolley P, Owen JR, Sandock K, Lewis TH, Bates JN, Robertson TP, Lewis SJ. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors. Neuroscience. 2006 Nov 17;143(1):273-87. doi: 10.1016/j.neuroscience.2006.07.032. Epub 2006 Oct 9. PMID: 17029799. 3: Owen JR, Bates JN, Lewis SJ. Differential effects of nitroblue tetrazolium on the hemodynamic responses elicited by activation of alpha1-adrenoceptors and 5-HT2 receptors in conscious rats. Eur J Pharmacol. 2006 Mar 27;535(1-3):248-52. doi: 10.1016/j.ejphar.2006.01.060. Epub 2006 Mar 9. PMID: 16527267. 4: Sipe K, Leventhal L, Burroughs K, Cosmi S, Johnston GH, Deecher DC. Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Res. 2004 Dec 3;1028(2):191-202. doi: 10.1016/j.brainres.2004.09.012. PMID: 15527744. 5: Dave KD, Quinn JL, Harvey JA, Aloyo VJ. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit. Pharmacol Biochem Behav. 2004 Mar;77(3):623-9. doi: 10.1016/j.pbb.2003.12.017. PMID: 15006475. 6: Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Owton WM, Phebus LA. Neurogenic dural protein extravasation induced by meta- chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia. 2003 Mar;23(2):117-23. doi: 10.1046/j.1468-2982.2003.00464.x. PMID: 12603368. 7: Yamada J, Sugimoto Y, Yoshikawa T, Horisaka K. Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT2A receptor. Eur J Pharmacol. 1997 Apr 4;323(2-3):235-40. doi: 10.1016/s0014-2999(97)00029-0. PMID: 9128844. 8: Danuser H, Thor KB. Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. Br J Pharmacol. 1996 May;118(1):150-4. doi: 10.1111/j.1476-5381.1996.tb15378.x. PMID: 8733588; PMCID: PMC1909481. 9: Chaouche-Teyara K, Fournier B, Safar M, Dabiré H. Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat. Clin Exp Hypertens. 1994 Nov;16(6):779-98. doi: 10.3109/10641969409078025. PMID: 7858559. 10: Zabik JE, Sprague JE, Binkerd K. Central and peripheral components of the inhibitory actions of 5-HTP on ethanol consumption in the rat. Pharmacol Biochem Behav. 1994 Mar;47(3):547-51. doi: 10.1016/0091-3057(94)90157-0. PMID: 8208773. 11: Eberle-Wang K, Braun BT, Simansky KJ. Serotonin contracts the isolated rat pylorus via a 5-HT2-like receptor. Am J Physiol. 1994 Jan;266(1 Pt 2):R284-91. doi: 10.1152/ajpregu.1994.266.1.R284. PMID: 8304552. 12: Lawton CL, Blundell JE. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI. Pharmacol Biochem Behav. 1993 Oct;46(2):349-60. doi: 10.1016/0091-3057(93)90363-x. PMID: 8265689. 13: Bailey SP, Davis JM, Ahlborn EN. Serotonergic agonists and antagonists affect endurance performance in the rat. Int J Sports Med. 1993 Aug;14(6):330-3. doi: 10.1055/s-2007-1021187. PMID: 8407063. 14: Chaouche-Teyara K, Dabiré H, Fournier B, Safar M. Participation périphérique et centrale aux effets hémodynamiques de la stimulation des récepteurs sérotoninergiques2 [Peripheral and central participation in hemodynamic effects of serotonin2 receptor stimulation]. Arch Mal Coeur Vaiss. 1993 Aug;86(8):1257-61. French. PMID: 8129539. 15: Grignaschi G, Mantelli B, Samanin R. The hypophagic effect of restraint stress in rats can be mediated by 5-HT2 receptors in the paraventricular nucleus of the hypothalamus. Neurosci Lett. 1993 Apr 2;152(1-2):103-6. doi: 10.1016/0304-3940(93)90494-6. PMID: 8515859. 16: Pérgola PE, Sved AF, Voogt JL, Alper RH. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology. 1993 Mar;57(3):550-8. doi: 10.1159/000126404. PMID: 8321422. 17: Meller ST, Lewis SJ, Brody MJ, Gebhart GF. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Brain Res. 1992 Jul 10;585(1-2):71-86. doi: 10.1016/0006-8993(92)91192-h. PMID: 1511336. 18: Bond EF, Heitkemper MM, Gruver MK. Mediation of thyrotropin-releasing hormone induced gastric motility increases in developing rats. Eur J Pharmacol. 1992 Jul 7;217(2-3):127-35. doi: 10.1016/0014-2999(92)90831-n. PMID: 1425933. 19: Yamada J, Sugimoto Y, Kimura I, Watanabe Y, Takeuchi N, Horisaka K. Hyperglucagonemia induced in mice by tryptamine: involvement of the peripheral 5-HT2 receptors. Eur J Pharmacol. 1992 Jun 5;216(2):307-10. doi: 10.1016/0014-2999(92)90375-e. PMID: 1397014. 20: Grignaschi G, Samanin R. Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine. Neuropharmacology. 1992 May;31(5):445-9. doi: 10.1016/0028-3908(92)90082-z. PMID: 1528396.